A skin permeability model of insulin in the presence of chemical penetration enhancer

International Journal of Pharmaceutics

Volumn 388, Issue 1-2, 2010, Pages 13-23

  Yerramsetty, K M ^a   Neely, B J ^a   Madihally, S V ^a   Gasem, K A M ^a  

^a Oklahoma State University   (United States)

Author keywords

Chemical penetration enhancer; Permeability; Quantitative structure property relationship; Transdermal

Indexed keywords

INSULIN; PENETRATION ENHANCING AGENT;

ALGORITHM; ANIMAL TISSUE; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; LIPID BILAYER; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE PROPERTY RELATION; SKIN PERMEABILITY; SKIN STRUCTURE; STATISTICAL MODEL;

ADMINISTRATION, CUTANEOUS; ALGORITHMS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; EXCIPIENTS; HYPOGLYCEMIC AGENTS; INSULIN; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); NONLINEAR DYNAMICS; PERMEABILITY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SKIN; SKIN ABSORPTION; SWINE;

EID: 76549090086     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.028     Document Type: Article

References (54)

1. Abraham M.H., and Martins F. Human skin permeation and partition: general linear free-energy relationship analyses. J. Pharm. Sci. 93 (2004) 1508-1523
2. Agatonovic-Kustrin S., Beresford R., and Yusof A.P. ANN modeling of the penetration across a polydimethylsiloxane membrane from theoretically derived molecular descriptors. J. Pharm. Biomed. Anal. 26 (2001) 241-254
3. Aoki I., and Komatsu T. Analysis and prediction of the fluctuation of sardine abundance using a neural network. Oceanol. Acta 20 (1997) 81-88
4. Barratt M.D. Quantitative structure-activity relationships for skin permeability. Toxicol. In Vitro 9 (1995) 27-37
5. CambridgeSoft, 2008. Chembiooffice 11.0. Cambridge Software.
6. Chantasart D., Li S.K., He N., Warner K.S., Prakongpan S., and Higuchi W.I. Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J. Pharm. Sci. 93 (2004) 762-779
7. ChemAxon, 2007. Marvin and Calculator Plugin Demo. ChemAxon.
8. Choi E.H., Lee S.H., Ahn S.K., and Hwang S.M. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis. Skin Pharmacol. Appl. Skin Physiol. 12 (1999) 326-335
9. Garson G.D. Interpreting neural-network connection weights. AI Expert 6 (1991) 46-51
10. Ghafourian T., Zandasrar P., Hamishekar H., and Nokhodchi A. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J. Control. Release 99 (2004) 113-125
11. Godavarthy S.S., Yerramsetty K.M., Rachakonda V.K., Neely B.J., Madihally S.V., Robinson Jr. R.L., and Gasem K.A.M. Design of improved transdermal drug delivery permeation enhancers. J. Pharm. Sci. 98 (2009) 4085-4099
12. Guy R.H., and Potts R.O. Penetration of industrial chemicals across the skin: a predictive model. Am. J. Ind. Med. 23 (1993) 711-719
13. Hall L.H., Kier L.B., and Murray W.J. Molecular connectivity II: relationship to water solubility and boiling point. J. Pharm. Sci. 64 (1975) 1974-1977
14. Hao J.S., Zheng J.M., and Yang W.Z. Transdermal iontophoresis of insulin: effect of penetration enhancers on blood glucose level in diabetic rats. Yao Xue Xue Bao 30 (1995) 776-780
15. Hornik K., Stinchcombe M., and White H. Multilayer feedforward networks are universal approximators. Neural Networks 2 (1989) 359-366
16. Hrabalek A., Vavrova K., Dolezal P., and Machacek M. Esters of 6-aminohexanoic acid as skin permeation enhancers: The effect of branching in the alkanol moiety. J. Pharm. Sci. 94 (2005) 1494-1499
17. Iyer M., Zheng T., Hopfinger A.J., and Tseng Y.J. QSAR analyses of skin penetration enhancers. J. Chem. Inf. Model. 47 (2007) 1130-1149
18. Kang L., Yap C.W., Lim P.F.C., Chen Y.Z., Ho P.C., Chan Y.W., Wong G.P., and Chan S.Y. Formulation development of transdermal dosage forms: Quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. J. Control. Release 120 (2007) 211-219
19. Katritzky A.R., Lobanov V.S., and Karelson M. CODESSA User's Manual (1994), University of Florida, Gainsville
20. Kier L.B., and Hall L.H. Molecular connectivity VII: specific treatment of heteroatoms. J. Pharm. Sci. 65 (1976) 1806-1809
21. Kier L.B., and Hall L.H. Intermolecular accessibility: the meaning of molecular connectivity. J. Chem. Inf. Comput. Sci. 40 (2000) 792-795
22. Li C.J., Obata Y., Higashiyama K., Nagai T., and Takayama K. Effect of 1-O-ethyl-3-butylcyclohexanol on the skin permeation of drugs with different physicochemical characteristics. Int. J. Pharm. 259 (2003) 193-198
23. Mathworks, 2005. MATLAB. Novi, Michigan, The Mathworks Inc.
24. Mazzenga, G.C., Berner, B., 1990. Transdermal administration of zwitterionic drugs. USA.
25. Mitragotri S., Blankschtein D., and Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 13 (1996) 411-420
26. Monteiro-Riviere N.A. Comparative anatomy, physiology, and biochemistry of mammalian skin. In: Hobson D.W. (Ed). Dermal and Ocular Toxicology: Fundamentals and Methods. 1st ed. (1991), CRC Press, Boca Raton, FL
27. Monteiro-Riviere N.A. Anatomical factors affecting barrier function. In: Marzulli F.N., and Maibach H.I. (Eds). Dermatotoxicology. 1st ed. (1996), Taylor & Francis, Washington, DC
28. Murray W.J., Hall L.H., and Kier L.B. Molecular connectivity III: relationship to partition coefficients. J. Pharm. Sci. 64 (1975) 1978-1981
29. Narishetty S.T.K., and Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J. Control. Release 95 (2004) 367-379
30. Narishetty S.T.K., and Panchagnula R. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation. Biopharm. Drug Dispos. 25 (2004) 9-20
31. Neumann D., Kohlbacher O., Merkwirth C., and Lengauer T. A fully computational model for predicting percutaneous drug absorption. J. Chem. Inf. Model. 46 (2006) 424-429
32. Olden J.D., and Jackson D.A. Illuminating the "black box": a randomization approach for understanding variable contributions in artificial neural networks. Ecol. Model. 154 (2002) 135-150
33. Patni P., Varghese D., Balekar N., and Jain D.K. Needle-free insulin drug delivery. Indian J. Pharm. Sci. 68 (2006) 7-12
34. Pillai O., Borkute S.D., Sivaprasad N., and Panchagnula R. Transdermal iontophoresis of insulin. II. Physicochemical considerations. Int. J. Pharm. 254 (2003) 271-280
35. Pillai O., Kumar N., Dey C.S., Borkute S., Nagalingam S., and Panchagnula R. Transdermal iontophoresis of insulin. Part 1. A study on the issues associated with the use of platinum electrodes on rat skin. J. Pharm. Pharmacol. 55 (2003) 1505-1513
36. Pillai O., Kumar N., Dey C.S., Borkute S., Nagalingam S., and Panchagnula R. Transdermal iontophoresis of insulin. III. Influence of electronic parameters. Methods Finds Exp. Clin. Pharmacol. 26 (2004) 399-408
37. Pillai O., Nair V., and Panchagnula R. Transdermal iontophoresis of insulin. IV. Influence of chemical enhancers. Int. J. Pharm. 269 (2004) 109-120
38. Pillai O., and Panchagnula R. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J. Control. Release 89 (2003) 127-140
39. Pillai O., and Panchagnula R. Transdermal iontophoresis of insulin. V. Effect of terpenes. J. Control. Release 88 (2003) 287-296
40. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1992) 663-669
41. Priborsky J., Takayama K., Nagai T., Waitzova D., Elis J., Makino Y., and Suzuki Y. Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-l-pyroglutamate. Pharm. Weekbl. Sci. 10 (1988) 189-192
42. Price K.V., Storn R.M., and Lampinen J.A. Differential Evolution: A Practical Approach to Global Optimization (2005), Springer Verlag
43. Rachakonda V.K., Yerramsetty K.M., Madihally S.V., Robinson Jr. R.L., and Gasem K.A.M. Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin. Pharm. Res. 25 (2008) 2697-2704
44. Rao V.U., and Misra A.N. Enhancement of iontophoretic permeation of insulin across human cadaver skin. Die Pharmazie 49 (1994) 538-539
45. Rastogi S.K., and Singh J. Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: permeability and Fourier transform infrared spectroscopy studies. AAPS PharmSciTech 4 (2003) 1-9
46. Rastogi S.K., and Singh J. Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis. Pharm. Dev. Technol. 10 (2005) 97-104
47. Scheuplein R.J., and Blank I.H. Permeability of the skin. Physiol. Rev. 51 (1971) 702-747
48. Scheuplein R.J., and Blank I.H. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 60 (1973) 286-296
49. Semichem, 1998a. AMPAC, 6.0. Shawnee, KS, Semichem Inc.
50. Semichem, 1998b. CODESSA, 2.7.8. Shawnee, KS, Semichem Inc.
51. Sintov A.C., and Wormser U. Topical iodine facilitates transdermal delivery of insulin. J. Control. Release 118 (2007) 185-188
52. Stoughton R.B. Percutaneous absorption of drugs. Annu. Rev. Pharmacol. Toxicol. 29 (1989) 55-69
53. Tropsha A., Gramatica P., and Gombar V.K. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb. Sci. 22 (2003) 69-77
54. Turner J.V., Maddalena D.J., and Agatonovic-Kustrin S. Bioavailability prediction based on molecular structure for a diverse series of drugs. Pharm. Res. 21 (2004) 68-82